ClinicalTrials.Veeva

Menu

Uterocervical Angle: a Screening Tool That Estimates the Latent Phase Duration in Post Term Pregnancies

S

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Status

Completed

Conditions

Post Term Pregnancy

Treatments

Other: latent phase duration
Other: uterocervical angle (UCA)

Study type

Interventional

Funder types

Other

Identifiers

NCT04848701
20.11.31

Details and patient eligibility

About

To evaluate the performance of uterocervical angle (UCA) in the prediction of latent phase duration in post term pregnancies

Enrollment

90 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with singleton pregnancies
  • Post term pregnancies
  • Patients with vertex presentation,
  • Patients with intact membranes
  • Patients with no uterine contractions

Exclusion criteria

  • women with BMI >30,
  • multiparity and multiple pregnancies,
  • patients with macrosomia (>4500 gr),
  • patients with major fetal congenital abnormality or fetal death and any contraindications to vaginal birth (e.g. active genital herpes),
  • patients with abnormal Pap smears,
  • patients with a history of previous cesarean section, myomectomy, hysteroscopic surgeries, dilatation and curettages, loop electrosurgical excision procedures, and cervical conization.

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

90 participants in 1 patient group

uterocervical angle
Other group
Description:
uterocervical angle is the angle between lower segment of uterus and cervix
Treatment:
Other: latent phase duration
Other: uterocervical angle (UCA)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems